Literature DB >> 1725152

Efficacy and tolerability of cefixime in otitis media. A multicentre study in over 25,000 children.

D H Wu1.   

Abstract

A large scale multicentre clinical study was undertaken to assess the efficacy and tolerability of cefixime in the treatment of acute otitis media in children. A total of 25,863 evaluable children with acute otitis media received cefixime 8 mg/kg once daily for at least 10 days. At the end of treatment, 86% of patients were considered to be either cured or improved. These results are consistent with those achieved with cefixime in controlled clinical trials. Adverse effects were reported in 11.5% of patients, but were judged to be related to cefixime therapy in only 9.4% of patients. The results of this study demonstrate that cefixime is an effective and well tolerated treatment for acute otitis media in children.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725152     DOI: 10.2165/00003495-199100424-00009

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  5 in total

1.  Amoxicillin as the drug of choice for acute otitis media: isn't it time for its reassessment in some areas of the country?

Authors:  R H Schwartz; W J Rodriguez
Journal:  Pediatr Infect Dis J       Date:  1989-11       Impact factor: 2.129

2.  Importance of patient compliance in effective antimicrobial therapy.

Authors:  D A Hussar
Journal:  Pediatr Infect Dis J       Date:  1987-10       Impact factor: 2.129

3.  beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children.

Authors:  A L Kovatch; E R Wald; R H Michaels
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

Review 4.  Infection and Branhamella catarrhalis.

Authors:  D T McLeod; F Ahmad; M A Calder
Journal:  Biomed Pharmacother       Date:  1985       Impact factor: 6.529

5.  Acute otitis media caused by Branhamella catarrhalis: biology and therapy.

Authors:  G F Van Hare; P A Shurin; C D Marchant; N A Cartelli; C E Johnson; D Fulton; S Carlin; C H Kim
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb
  5 in total
  1 in total

1.  Third generation cephalosporins in the parenteral to oral switch.

Authors:  D Rimmer
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.